Financing ·
Jaguar Health, Inc. completed the conversion of its Series O Preferred Stock into Common Stock at a conversion ratio…
JAGXJaguar Health, Inc.
Jaguar Health, Inc. completed the conversion of its Series O Preferred Stock into Common Stock at a conversion ratio of 3.209 shares of Common Stock for each share of Series O Preferred Stock on June 25, 2026. Following the conversion, there were 4,857,211 shares of Common Stock issued and outstanding. Jaguar Health, Inc. operates in the healthcare industry and develops medical devices and supplements for gastrointestinal health.